Sequent Scientific Quarterly Results for Trading Insights
SEQUENT • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹20 Cr
QSept 2025
Sequent Scientific Quarterly Results Key Highlights
- Revenue of ₹426 Cr in Sept 2025 (+5.7% vs Mar 2025, +14.2% vs Sept 2024)
- Net Profit of ₹20 Cr in Sept 2025 (+100.0% vs Mar 2025, +233.3% vs Sept 2024)
- EBITDA of ₹56 Cr in Sept 2025 (+16.7% vs Mar 2025)
- Operating Margin of 13.0% in Sept 2025 (+2.0pp vs Mar 2025)
- Earnings Per Share of ₹0.59 in Sept 2025 (+59.5% vs Mar 2025)
Sequent Scientific Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 426 | 403 | 445 | 373 | 365 | 5.7% | 14.2% |
| Net Profit (₹ Cr) | 20 | 10 | 18 | 6 | 1 | - | - |
| EBITDA (₹ Cr) | 56 | 48 | 55 | 39 | 32 | - | - |
| EPS (₹) | 0.59 | 0.37 | 0.57 | 0.11 | -0.04 | - | - |
| Operating Margin (%) | 13.0% | 11.0% | 12.0% | 9.0% | 8.0% | - | - |
Sequent Scientific Share Price Trend Around Quarterly Results
Visualize Sequent Scientific's 1-year price movement across quarterly results — ideal for logging trades in Sequent Scientific share price
chart using Tickjournal. All values in ₹.
Related Pages for Sequent Scientific
Additional stock information and data for SEQUENT
Revenue Trend (₹ Cr)
Sept 2024
373
Jun 2025
445
Mar 2025
403
Sept 2025
426
Net Profit Trend (₹ Cr)
Sept 2024
6
Jun 2025
18
Mar 2025
10
Sept 2025
20
Operating Margin Trend (%)
Sept 2024
9.0%
Jun 2025
12.0%
Mar 2025
11.0%
Sept 2025
13.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Sequent Scientific quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores